ICCM (Icecure Medical) Cyclically Adjusted PB Ratio: (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ICCM Icecure Medical Ltd ICCM
46 GF Score
Price $1.95
GF Value $20.03
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Icecure Medical Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Icecure Medical  (NAS:ICCM) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Icecure Medical Cyclically Adjusted PB Ratio Related Terms


Icecure Medical Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Icecure Medical's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Icecure Medical Cyclically Adjusted PB Ratio Chart

Icecure Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.40 0.25 0.56 1.65 1.08

Icecure Medical Quarterly Data
Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.46 1.50 1.08 0.52 0.28

ICCM vs TRIB, AIDX, NVNO: Cyclically Adjusted PB Ratio Comparison

For the Medical Devices subindustry, Icecure Medical's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Icecure Medical Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Icecure Medical's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Icecure Medical's Cyclically Adjusted PB Ratio falls into.


ICCM
46GF Score
Icecure Medical Ltd ICCM
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Icecure Medical Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Icecure Medical's Cyclically Adjusted Book per Share for the fiscal year that ended in Dec25 is calculated as:

For example, Icecure Medical's adjusted Book Value per Share data for the fiscal year that ended in Dec25 was:

Adj_Book=Book Value per Share/CPI of Dec25 (Change)*Current CPI (Dec25)
=3.713/324.0540*324.0540
=3.713

Current CPI (Dec25) = 324.0540.

Icecure Medical Annual Data

Book Value per Share CPI Adj_Book
201612 10.426 241.432 13.994
201712 -1.259 246.524 -1.655
201812 7.856 251.233 10.133
201912 5.159 256.974 6.506
202012 65.785 260.474 81.843
202112 22.178 278.802 25.778
202212 16.402 296.797 17.908
202312 7.829 306.746 8.271
202412 3.591 315.605 3.687
202512 3.713 324.054 3.713

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Icecure Medical (ICCM) Overvalued in 2026?

Based on GuruFocus' analysis, Icecure Medical stock appears to be undervalued. The current stock price of $1.95 is trading 90.3% below its estimated GF Value™ of $20.03. GuruFocus considers Icecure Medical to be Possible Value Trap.

Key valuation signals for ICCM:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: $20.03 vs. price of $1.95 (90.3% below fair value)
  • GF Score™: 46/100 with 4 warning signs

No single metric tells the full story. See the ICCM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Icecure Medical Business Description

Address 7 Haeshel Street, PO Box 3163, Caesarea, ISR, 3079504
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
46GF Score

Get the complete analysis for ICCM

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.95
Price
$20.03
GF Value